Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MedAdvisor Limited ( (AU:MDR) ) has issued an announcement.
MedAdvisor Limited announced the quotation of 469,046 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from July 14, 2025. This move reflects the company’s strategic efforts to enhance its financial positioning and potentially expand its market presence, offering implications for stakeholders regarding increased liquidity and investment opportunities.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, providing digital solutions to improve medication management. The company focuses on enhancing patient engagement and adherence through its innovative platforms, serving a broad market that includes pharmacies and healthcare providers.
Average Trading Volume: 1,027,801
Technical Sentiment Signal: Sell
Current Market Cap: A$33.11M
For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.